SCHEMBL8185201

SCHEMBL8185201

CCCCN1C[C@H](CO)[C@@H](O)[C@H](OCc2ccccc2)C1

nearest known ligand 0.54

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PYGL P06737 1/20 0.54
GBA1 P04062 7/20 0.52
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
GLB1 P16278 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8181124 0.95 GBA1 (0.54) PYGLGBA1BCHEACHE
SCHEMBL8187378 0.95 GBA1 (0.54) PYGLGBA1BCHEACHE
SCHEMBL8176411 0.89 PYGL (0.69) PYGLGBA1SIGMAR1
SCHEMBL8172188 0.88 GBA1 (0.58) PYGLGBA1
SCHEMBL440211 0.84 GBA1 (0.66) PYGLGBA1
SCHEMBL2454394 0.84 GBA1 (0.66) PYGLGBA1
SCHEMBL403643 0.84 GBA1 (0.66) PYGLGBA1
SCHEMBL8181071 0.83 PYGL (0.49) PYGLGBA1SIGMAR1
SCHEMBL8187072 0.82 GBA1 (0.47) PYGLGBA1
SCHEMBL14388983 0.81 GBA1 (0.59) PYGLGBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6046214-A USEFUL IN TREATMENT AND/OR PREVENTION OF DIABETES, AND ESPECIALLY NON-INSULIN DEPENDENT DIABETES (NIDDM OR TYPE 2 DIABETES) INCLUDING OVERNIGHT OR MEAL TREATMENT AND TREATMENT OR PREVENTION OF LONGTERM COMPLICATIONS, SUCH AS RETINOPATHY NOVO NORDISK A/S (DK) 2000-04-04 US disclosed
EP-0983239-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 2000-03-08 EP disclosed
WO-1998050359-A1 NOVEL HETEROCYCLIC COMPOUNDS NOVO NORDISK A/S (DK) 1998-11-12 WO disclosed